朗生醫藥(00503.HK):預計上半年溢利同比將錄得顯著跌幅
格隆匯7月29日丨朗生醫藥(00503.HK)發佈公吿,根據初步估算,截至2021年6月30日止六個月:集團的收入與去年同期相比將錄得適度跌幅;集團的經營溢利與去年同期相比將錄得顯著跌幅;及集團溢利與去年同期相比將錄得顯著跌幅。
集團的收入跌幅主要由於集團主要產品帕夫林和新適確得於該期的銷售量較去年同期下降。集團已關注到銷售量下降的情況,並正在調整銷售策略。集團的經營溢利跌幅主要歸因於上述收入下跌,導致毛利相應下跌。
集團的溢利跌幅主要由於去年同期有司太立的權益重分類為按公平值計入損益的金融資產錄得的一次性淨收益,該期並沒有錄得此一次性收益。此外,該期該按公平值計入損益的金融資產的價值變動錄得未變現虧損,於去年同期則錄得未變現收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.